metricas
covid
Buscar en
Spanish Journal of Psychiatry and Mental Health
Toda la web
Inicio Spanish Journal of Psychiatry and Mental Health Psychological impact during COVID-19 lockdown in children and adolescents with p...
Journal Information

Statistics

Follow this link to access the full text of the article

Original article
Psychological impact during COVID-19 lockdown in children and adolescents with previous mental health disorders
Jara Lopez-Serranoa,b,
Corresponding author
lopez38@clinic.cat

Corresponding author.
, Rosalía Díaz-Bóvedaa,b, Laura González-Vallespía,b, Pilar Santamarina-Péreza,b,c, Antonia Bretones-Rodrígueza,b, Rosa Calvoa,b,c,d, Sara Lera-Miguela,b
a Department of Child and Adolescent Psychiatry and Psychology, Hospital Clínic, C/VIllaroel 170, 08036 Barcelona, Spain
b University of Barcelona, Barcelona, Spain
c August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain
d Biomedical Research Networking Centre Consortium (CIBERSAM), Madrid, Spain
Read
1544
Times
was read the article
186
Total PDF
1358
Total HTML
Share statistics
Article information
ISSN: 29502853
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 December 28 6 34
2024 November 47 6 53
2024 October 54 4 58
2024 September 77 8 85
2024 August 32 13 45
2024 July 52 8 60
2024 June 48 10 58
2024 May 77 17 94
2024 April 121 11 132
2024 March 151 14 165
2024 February 113 7 120
2024 January 157 1 158
2023 December 79 15 94
2023 November 75 6 81
2023 October 65 25 90
2023 September 25 1 26
2023 August 25 2 27
2023 July 17 2 19
2023 June 21 2 23
2023 May 45 0 45
2023 April 49 3 52
2023 February 0 3 3
2022 October 0 6 6
2022 August 0 2 2
2022 April 0 4 4
2022 March 0 6 6
2022 January 0 4 4
Show all

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos